In its recent recommendation on screening for cognitive impairment in older adults, the US Preventive Services Task Force (USPSTF) concludes that “the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults (I statement).”1 This conclusion, supported by an updated evidence report and systematic review,2 is the same one the task force reached in 2014 after similar extensive scrutiny of the evidence base.3 There continues to be insufficient evidence with which to evaluate the benefits and harms of systematic cognitive testing in asymptomatic people 65 years and older. Given the burden of dementia and the intense public interest in preventing cognitive impairment, the lack of progress is disheartening.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Brayne C. Evidence Still Lacking for Recommendation of Screening for Cognitive Impairment in Older Adults. JAMA Intern Med. 2020;180(4):483–484. doi:10.1001/jamainternmed.2019.7522
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: